DI TARANTO, MARIA DONATA
 Distribuzione geografica
Continente #
NA - Nord America 1.229
EU - Europa 645
AS - Asia 464
AF - Africa 39
SA - Sud America 2
Totale 2.379
Nazione #
US - Stati Uniti d'America 1.187
IT - Italia 348
SG - Singapore 271
CN - Cina 148
NL - Olanda 87
DE - Germania 47
IE - Irlanda 41
CA - Canada 39
CI - Costa d'Avorio 39
FI - Finlandia 37
VN - Vietnam 26
SE - Svezia 20
GB - Regno Unito 11
UA - Ucraina 11
RO - Romania 10
IN - India 9
FR - Francia 8
HK - Hong Kong 7
CH - Svizzera 5
CZ - Repubblica Ceca 4
BE - Belgio 3
BG - Bulgaria 3
MX - Messico 3
BR - Brasile 2
RU - Federazione Russa 2
SK - Slovacchia (Repubblica Slovacca) 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AT - Austria 1
ES - Italia 1
HR - Croazia 1
IR - Iran 1
LT - Lituania 1
MT - Malta 1
SA - Arabia Saudita 1
Totale 2.379
Città #
Singapore 236
Chandler 223
Ashburn 96
Amsterdam 84
Naples 68
Napoli 67
Millbury 66
Boardman 43
Princeton 41
Boston 37
Nanjing 37
Santa Clara 36
Des Moines 32
Ottawa 32
Beijing 30
Lawrence 27
Dong Ket 26
Wilmington 17
Jacksonville 14
Rome 14
Washington 14
Nanchang 13
Woodbridge 13
Milan 12
Augusta 10
Dublin 10
Los Angeles 10
Redwood City 10
Timisoara 10
Norwalk 9
Shenyang 9
Cercola 7
Dallas 7
Ercolano 7
Hebei 7
Seattle 7
Tianjin 6
Kronberg 5
Marsala 5
Rimini 5
Central 4
Forlì 4
Formia 4
Hangzhou 4
Mariglianella 4
Santa Maria Capua Vetere 4
Brussels 3
Caserta 3
Houston 3
Nocera Superiore 3
Redmond 3
San Mateo 3
Shanghai 3
Sofia 3
Toronto 3
Zurich 3
Alcamo 2
Andradas 2
Bologna 2
Bratislava 2
Brno 2
Casal di Principe 2
Changchun 2
Changsha 2
Chicago 2
Delhi 2
Florence 2
Hanover 2
Helsinki 2
Jiaxing 2
Kunming 2
Lanzhou 2
Lappeenranta 2
Leawood 2
Mexico 2
Monreale 2
Mountain View 2
Munich 2
New York 2
Palermo 2
Portici 2
Rovigo 2
Sham Shui Po 2
Torre Del Greco 2
Abidjan 1
Afragola 1
Arzano 1
Bacoli 1
Brusciano 1
Caravaggio 1
Casalnuovo Di Napoli 1
Casoria 1
Cava de' Tirreni 1
Cellole 1
Coimbatore 1
Cologne 1
Denver 1
Dubai 1
Duncan 1
Fairfield 1
Totale 1.528
Nome #
Galectin-3 and Lp(a) plasma concentrations and advanced carotid atherosclerotic plaques: correlation with plaque presence and features 98
A case of cerebrotendinous xanthomatosis in a woman with a normal cholesterolemia. 52
Cerebrotendinous xanthomatosis, a metabolic disease with different neurological signs: two case reports 52
EXPRESSION OF ADIPONECTIN RECEPTORS IN HUMAN CAROTID ATHEROSCLEROTIC PLAQUES Abstracts from the 12th National Congress of the Italian Society of Cardiovascular Prevention (SIPREC), Naples, 6–8 March 2014 51
A wide next-generation-sequencing panel improves the molecular diagnosis of dyslipidemias 51
C-reactive protein levels are associated with paraoxonase polymorphism L55M in patients undergoing cardiac SPECT imaging 49
Causative mutations and premature cardiovascular disease in patients with heterozygous familial hypercholesterolaemia 48
Identification and functional characterization of LDLR mutations in familial hypercholesterolemia patients from Southern Italy 45
Expression of inflammation-related genes in human atherosclerotic plaques. 43
Familial hypercholesterolemia: A complex genetic disease with variable phenotypes 43
Identification of deletions in LDLR gene by Multiplex Ligation-Dependent Probe Amplification Analysis. 42
Association of USF1 and APOA5 polymorphisms with familial combined hyperlipidemia in an Italian population. 42
Carotid Endarterectomy versus Carotid Artery Stenting with Double-Layer Micromesh Carotid Stent: contemporary results of a single-center retrospective study 42
Polymorphisms and the expression of genes encoding enzymes involved in cardiovascular diseases 41
Homocysteine levels and sustained virological response to pegylated-interferon alpha2b plus ribavirin therapy for chronic hepatitis C: a prospective study. 40
Identificazione e caratterizzazione funzionale di mutazioni nel gene LDLR in pazienti del sud Italia affetti da Ipercolesterolemia familiare. 40
Investigation of Single Nucleotide Polymorphisms Associated to Familial Combined Hyperlipidemia with Random Forests. 39
Endovascular Treatment Versus Medical Therapy for Hypertensive Patients with Renal Artery Stenosis: An Updated Systematic Review 39
Genetic Heterogeneity of Familial Hypercholesterolemia: Repercussions for Molecular Diagnosis 38
Decreased Paraoxonase-2 Expression in Human Carotids During the Progression of Atherosclerosis 38
A first comparative study on two cell colture techniques – stimulated T cells and continous lymphoblastoid cell lines – in the detection of LDL receptor residual activity versus molecular genetic analysys 38
Familial hypercholesterolemia: The Italian Atherosclerosis Society Network (LIPIGEN) 38
Age-related changes of cholestanol and lathosterol plasma concentrations: An explorative study 38
Relazione tra polimorfismi del gene paraoxonasi ed ischemia miocardica indotta da stress in pazienti con sospetta malattia coronarica 37
A case of cerebrotendinous xantomatosis in a woman with a normal colesterolemia 36
An improved method on stimulated T-lymphocytes to functionally characterize novel and known LDLR mutations. 36
Correlation between low adenosine A2A receptor expression and hypercholesterolemia: A new component of the cardiovascular risk? 36
Genetic spectrum of familial hypercholesterolemia and correlations with clinical expression: Implications for diagnosis improvement 36
Expression of inflammation-related genes in human atherosclerotic plaque. 35
The role of galectin-3 and LP(A) in atherosclerosis: A combined analysis of serum levels and plaque characteristics 35
Functional characterization of mutant genes associated with autosomal dominant familial hypercholesterolemia: Integration and evolution of genetic diagnosis 35
Lipid profile and genetic status in a familial hypercholesterolemia pediatric population: exploring the LDL/HDL ratio 35
Association between causative mutations and response to PCSK9 inhibitor therapy in subjects with familial hypercholesterolemia: A single center real-world study 35
Identification of deletions in LDRR gene by multiplex ligation-dependent probe amplification analysis 34
Identification and functional characterization of a new mutation leading to defective uptake of LDL-LDLR complex. 34
Familial hypercholesterolemia: a flow chart for the molecular diagnosis. 34
Familial Combined Hyperlipidemia: identification of misdiagnosed patients by detection of LDLR mutations. 33
Altered expression of inflammation-related genes in human carotid atherosclerotic plaques. 33
Identification of Single Nucleotide Polymorphisms associated to Familial Combined Hyperlipidemia. 32
Valutazione di parametri di ossidazione in placche aterosclerotiche e plasma di pazienti endoarteriectomizzati. 32
Evaluation of the performance of Dutch Lipid Clinic Network score in an Italian FH population: The LIPIGEN study 32
The Arg499His gain-of-function mutation in the C-terminal domain of PCSK9 32
Lipoprotein (a) is an independent predictor of cardiovascular events in Mediterranean women (Progetto Atena) 32
Targeting Nanostrategies for Imaging of Atherosclerosis 32
Characterization of two novel pathogenic variants at compound heterozygous status in lipase maturation factor 1 gene causing severe hypertriglyceridemia 31
A Real-World Experience of Clinical, Biochemical and Genetic Assessment of Patients with Homozygous Familial Hypercholesterolemia 31
The role of immunosuppressive therapy in aneurysmal degeneration of hemodialysis fistulas in renal transplant patients: Aneurysmatic arteriovenous fistula in transplant patients 31
Changes in carotid stiffness in patients with familial hypercholesterolemia treated with Evolocumab®: A prospective cohort study 30
Advances in Computational Methods for Genetic Diseases 29
A case of Cerebrotendinous Xanthomatosis with spinal cord involvement and without tendon xanthomas: identification of a new mutation of the CYP27A1 gene 28
The novel variant p.Ser465Leu in the PCSK9 gene does not account for the decreased LDLR activity in members of a FH family 27
Association between Inguinal Hernia and Arterial Disease: A Preliminary Report 27
Clinical and Pathological Correlations in Chronic Venous Disease 26
ECHOCARDIOGRAFIC ANDECO-DOPPLER ABNORMALITIESIN RELATION TO LDL CHOLESTEROLIN FAMILIAL HYPERCHOLESTEROLEMIA 25
Identification and in vitro characterization of two new PCSK9 Gain of Function variants found in patients with Familial Hypercholesterolemia 25
Endothelial function improvement in patients with familial hypercholesterolemia receiving PCSK-9 inhibitors on top of maximally tolerated lipid lowering therapy 25
Spectrum of mutations in Italian patients with familial hypercholesterolemia: New results from the LIPIGEN study 24
Identification of single nucleotide polymorphisms associated to familial combined hyperlipidemia 23
Calprotectin Levels and Neutrophil Count Are Prognostic Markers of Mortality in COVID-19 Patients 22
IDENTIFICATION AND FUNCTIONALCHARACTERIZATION OF A NEW MUTATIONLEADING TO DEFECTIVE UPTAKEOF LDL-LDLR COMPLEX 22
SMALL DENSE LDL IN RELATION TO CHANGES IN OXIDATION MARKERS AND VASCULAR REACTIVITYIN PATIENTS WITH HYPERCHOLESTEROLEMIA TREATED WITH EVOLOCUMAB: A PROSPECTIVE COHORT STUDY 22
MANAGEMENT OF SEVEREHYPERCHOLESTEROLEMIA IN A FAMILYBEARING C.974G>A LDL RECEPTORMUTATION 21
IDENTIFICATION OF LDLR MUTATIONSIN PATIENTS WITH FAMILIAL COMBINEDHYPERLIPIDEMIA 20
Molecular diagnosis of Familial Hypercholesterolemia: the utility of a country specific protocol. 20
Metalloproteinases between History, Health, Disease, and the Complex Dimension of Social Determinants of Health 18
The Impact of Chronic Kidney Disease on Peripheral Artery Disease and Peripheral Revascularization 18
Studio del miRNome e caratterizzazione funzionale del LDLR per l’identificazione di nuove cause molecolari dell’ipercolesterolemia familiare [miRNome study and functional characterization of LDLR for the identification of new molecular causes of Familial Hypercholesterolemia] 16
Harnessing the potential of metalloproteinases in extracellular vesicles: a window of opportunity for aneurysm management 16
Multiparametric platform for profiling lipid trafficking in human leukocytes 16
Long-term hepatic safety of lomitapide in homozygous familial hypercholesterolaemia 16
Changes in markers of subclinical atherosclerosis in patients with familial hypercholesterolemia treated with evolocumab: a prospective cohort study 15
Efficacy of Long-Term Treatment of Autosomal Recessive Hypercholesterolemia With Lomitapide: A Subanalysis of the Pan-European Lomitapide Study 14
Assessment of Platelet Aggregation and Thrombin Generation in Patients with Familial Chylomicronemia Syndrome Treated with Volanesorsen: A Cross-Sectional Study 14
The Role of Registers in Increasing Knowledge and Improving Management of Children and Adolescents Affected by Familial Hypercholesterolemia: the LIPIGEN Pediatric Group 11
Impact of 12-SNP and 6-SNP Polygenic Scores on Predisposition to High LDL-Cholesterol Levels in Patients with Familial Hypercholesterolemia 11
Statistical and Computational Methods for Genetic Diseases: An Overview 11
Galectin-3 in cardiovascular diseases 11
Lipoprotein(a) Genotype Influences the Clinical Diagnosis of Familial Hypercholesterolemia 9
Lipoprotein(a) and family history for cardiovascular disease in paediatric patients: A new frontier in cardiovascular risk stratification. Data from the LIPIGEN paediatric group 9
Contemporary lipid-lowering management and risk of cardiovascular events in homozygous familial hypercholesterolaemia: insights from the Italian LIPIGEN Registry 9
Refinement of the diagnostic approach for the identification of children and adolescents affected by familial hypercholesterolemia: Evidence from the LIPIGEN study 8
Sex Differences in Diagnosis, Treatment, and Cardiovascular Outcomes in Homozygous Familial Hypercholesterolemia 8
Association of Very Rare NOTCH2 Variants with Clinical Features of Alagille Syndrome 7
Simplified Criteria for Identification of Familial Hypercholesterolemia in Children: Application in Real Life 6
Homozygous Familial Hypercholesterolemia in Campania 3
Totale 2.518
Categoria #
all - tutte 12.459
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.459


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020134 0 0 0 0 13 11 23 14 5 20 31 17
2020/2021204 8 13 26 8 16 23 6 13 14 10 31 36
2021/2022423 21 5 2 14 14 22 7 17 32 15 116 158
2022/2023573 72 23 24 26 91 70 3 57 87 85 29 6
2023/2024503 30 69 40 35 28 49 12 70 4 20 76 70
2024/2025398 115 117 22 90 54 0 0 0 0 0 0 0
Totale 2.518